Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Wes Ashford?

Wes Ashford

Physician

Veterans Health Administration

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Veterans Health Administration

Find other employees at this company (6,818)

Background Information

Employment History

Clinical Professor

Stanford University


Consultant

Neurotez , Inc.


Clinical Professor (Affiliated)

Dept of Psychiatry, Stanford University


Manager, Geriatric Psychiatry Clinic

UCLA


Affiliations

Neurobehavior Clinic

Founding Member


Medafile

Founder


Cognitive Labs

Member, Management Advisory Team


Education

B.S.

UC-Berkeley


B.S.

University of California at Berkeley


BA

University of California , Berkeley


M.D.

David Geffen School of Medicine at UCLA


M.D.

UCLA-Geffen School of Medicine


Ph.D.

Neuroscience

UCLA


Web References(23 Total References)


www.worldbrainmapping.org

Dr. Ashford is a Clinical Professor of Psychiatry and Behavioral Sciences (affiliated) at Stanford University and the Director of the War Related Illness and Injury Study Center at the VA Palo Alto Health Care System.
Dr. Ashford also serves as a Senior Research Scientist at the Stanford / VA Aging and Alzheimer's Disease Clinical Research Centers. He is Chair of the Memory Screening Advisory Board of the Alzheimer's Foundation of America and a Senior Editor of the Journal of Alzheimer's Disease. He received his MD (1974) and PhD (1984) from UCLA, completing his dissertation under Dr. Joaquin Fuster. His dissertation was a finalist for the Lindsley Prize for the best in Behavioral Neuroscience (1984). He completed Psychiatry Residency at the UCLA Neuropsychiatric Institute (1979; board certified in Psychiatry, 1981). While serving as the first Chief Resident on the UCLA Geriatric Psychiatry, unit 1978 to 1979, he conducted the first double-blind study of an anti-cholinesterase drug (physostigmine) to treat Alzheimer patients (Ashford et al., 1981); anti-cholinesterase drugs are now the first-line treatment for Alzheimer's dementia. From 1980 to 1985, Dr. Ashford directed the Geriatric Psychiatry Out-patient Clinic at UCLA and initiated the UCLA/Alzheimer PET scan study with Dr. David Kuhl. His work in Alzheimer's disease and neurophysiology led to the water-shed proposal that neuro-plastic memory mechanisms of the brain are specifically affected by Alzheimer pathology (Ashford & Jarvik, 1985, Ashford, 2015). Dr. Ashford has served in leadership positions in several academic institutions. He helped to establish NIA-funded Alzheimer's Disease Centers at Southern Illinois University School of Medicine and the University of California, Davis. While in Illinois he published the first study of Modern Test Theory in the field of Medicine, "Item-Response Theory" analysis of the Mini-Mental State Exam (Ashford et al., 1989). At the University of Kentucky, as tenured Associate Professor in Psychiatry, Neurology, and the Sanders-Brown Center on Aging, and Vice-Chair for Research, Department of Psychiatry, and a scientist in the NIA-funded Alzheimer's Disease Research Center, he proposed a "Time-Index" method to measure Alzheimer dementia severity (Ashford et al., 1995; Ashford & Schmitt, 2001), which was used in the UK Nun study (Butler, Ashford, Snowden, 1996), and a study of the loss of cerebral perfusion in Alzheimer patients (Ashford et al., 2000). In addition to publishing extensively in nearly all areas of the Alzheimer field, Dr. Ashford has studied numerous other neuropsychiatric illnesses. He provides leadership, mentorship and expert consultation in a wide range of fields touching on and synergistic to brain health and disease. He is currently developing early detection and measurement methods for cognitive function and reformulating theories of Alzheimer pathology. He continues his life-long interest and passion for improving health and slowing aging.


blog.cognitivelabs.com [cached]

Another new member of the team is Dr. Wes Ashford, senior scientist at the Stanford/VA NIH Alzheimer's Center, whose expertise is neuropsychological testing and the early incidence of Alzheimer's Disease.
Wes has a B.S. from UC-Berkeley, M.D. from UCLA-Geffen School of Medicine, and a Ph.D. in Neuroscience, also from UCLA. Here is a summary of Dr. Ashford's AlzForum' presentation on genetic risk factors for Alzheimer's Disease: The specific Gompertz parameters underlying AD are not understood, but even so, it is clear that ApoE genotype changes this curve, Ashford said. ApoE exerts its main effect by influencing when people get AD, Ashford said. In a clinic population, the E4/4 genotype reduces the mean age of onset to 68 from 74 in E3/3 carriers. Environmental factors and nonspecific genes also play a role in determining AD risk and may, in fact, have a relatively greater effect in very old age (see also Silverman et al., 2003). Ashford suggested that the E2 and E3 alleles, which evolved from the ancestral E4, better support the remodeling of dendrites and minimize neuronal stress over time (see also Live Discussion).


memtrax.com

MemTrax was founded by Dr. Wes Ashford, who has been developing the memory testing science behind MemTrax since 1985.
Dr. Ashford graduated from the University of California, Berkeley in 1970. At UCLA (1970 - 1985), he attained an M.D. (1974) and Ph.D. (1984). He trained in psychiatry (1975 - 1979) and was a founding member of the Neurobehavior Clinic and the first Chief Resident and Associate Director (1979 - 1980) on the Geriatric Psychiatry in-patient unit.


memtrax.com

As we continue our Alzheimer's Speaks Radio talk show discussion, Lori La Bey and Dr. Ashford, the inventor of MemTrax give their personal experiences with dealing with their parents as they digressed into Alzheimer's disease and dementia.
We learn from Dr. Ashford, an interesting health tip, that education and social interaction are very important stimulation that the brain requires to be healthy. Dr. Ashford : But she didn't tell you that's what she was doing? Lori : No, no, no... Dr. Ashford : Exactly. (Dr. Ashford solidifies his previous point in an earlier blog posts that some people with Alzheimer's and dementia will not mention or draw attention to their symptoms and ailments.) Dr. Ashford : Dr. Ashford : Dr. Ashford : I think that what the autopsy data shows, we are looking at people after they died, is very important. I think its a very good thing to look at a persons brain to see what was actually happening, Curtis already brought up the issue of my father having dementia, which I had the unfortunate experience of watching him from having a very good memory to gradually losing his memory. When he finally passed on I had his brain looked at to see what was actually happening. MemTrax was founded by Dr. Wes Ashford, who has been developing the memory testing science behind MemTrax since 1985. Dr. Ashford graduated from the University of California, Berkeley in 1970. At UCLA (1970 - 1985), he attained an M.D. (1974) and Ph.D. (1984). He trained in psychiatry (1975 - 1979) and was a founding member of the Neurobehavior Clinic and the first Chief Resident and Associate Director (1979 - 1980) on the Geriatric Psychiatry in-patient unit. MemTrax was founded by Dr. Wes Ashford, who has been developing the memory testing science behind MemTrax since 1985. Dr. Ashford graduated from the University of California, Berkeley in 1970. At UCLA (1970 - 1985), he attained an M.D. (1974) and Ph.D. (1984). He trained in psychiatry (1975 - 1979) and was a founding member of the Neurobehavior Clinic and the first Chief Resident and Associate Director (1979 - 1980) on the Geriatric Psychiatry in-patient unit. MemTrax was founded by Dr. Wes Ashford, who has been developing the memory testing science behind MemTrax since 1985. Dr. Ashford graduated from the University of California, Berkeley in 1970. At UCLA (1970 - 1985), he attained an M.D. (1974) and Ph.D. (1984). He trained in psychiatry (1975 - 1979) and was a founding member of the Neurobehavior Clinic and the first Chief Resident and Associate Director (1979 - 1980) on the Geriatric Psychiatry in-patient unit. 10 Tips to Keep Your Brain Healthy from Dr. Ashford


blog.cognitivelabs.com [cached]

For example, Wes Ashford of the Stanford/VA Alzheimer's Center has an interesting series of these "iconic" images, which we'll be posting, along with other top tests from known experts.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory